Literature DB >> 2990326

In vitro activity of the spermicide nonoxynol-9 against Chlamydia trachomatis.

J P Kelly, R B Reynolds, S Stagno, W C Louv, W J Alexander.   

Abstract

The in vitro activity of nonoxynol-9 against four serotypes (C, D, H, and K) of Chlamydia trachomatis was investigated. A constant inoculum of each serotype was exposed to serial twofold dilutions (1:100 to 1:800) of Koromex, Conceptrol, or reference preparations (not containing nonoxynol-9) for 4 and 24 h at 37 degrees C. The mixtures of nonoxynal-9 or nonnonoxynol preparations and control inocula were dispensed into triplicate wells containing McCoy cell monolayers. After incubation at 37 degrees C, the monolayers were fixed and stained with iodine and examined for evidence of infection with C. trachomatis. All nonoxynol-9-containing preparations showed marked antichlamydial activity as judged by percent reduction of glycogen-containing intracytoplasmic inclusions. The reference preparations, which did not contain nonoxynol-9, were markedly less active when tested in this in vitro system.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2990326      PMCID: PMC180148          DOI: 10.1128/AAC.27.5.760

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  13 in total

1.  Are chlamydial infections the most prevalent venereal disease?

Authors:  J Schachter; L Hanna; E C Hill; S Massad; C W Sheppard; J E Conte; S N Cohen; K F Meyer
Journal:  JAMA       Date:  1975-03-24       Impact factor: 56.272

2.  Inactivation of clinical isolates of Herpesvirus hominis, types 1 and 2, by chemical contraceptives.

Authors:  B Postic; B Singh; N L Squeglia; L O Guevarra
Journal:  Sex Transm Dis       Date:  1978 Jan-Mar       Impact factor: 2.830

3.  The expanding clinical spectrum of infections with chlamydia trachomatis.

Authors:  J Schacter
Journal:  Sex Transm Dis       Date:  1977 Jul-Sep       Impact factor: 2.830

4.  A note on the susceptibility of N. gonorrhoeae to contraceptive agent Nonyl-P.

Authors:  M E Cowan; G E Cree
Journal:  Br J Vener Dis       Date:  1973-02

5.  In vitro effects of Emko on Neisseria gonorrhoeae and Trichomonas vaginalis.

Authors:  O H Bolch; J C Warren
Journal:  Am J Obstet Gynecol       Date:  1973-04-15       Impact factor: 8.661

6.  The Chlamydia epidemic.

Authors:  K K Holmes
Journal:  JAMA       Date:  1981-05-01       Impact factor: 56.272

7.  Studies on the development of a vaginal preparation providing both prophylaxis against venereal disease and other genital infections and contraception. II. Effect in vitro of vaginal contraceptive and non-contraceptive preparations on Treponema pallidum and Neisseria gonorrhoeae.

Authors:  B Singh; J C Cutler; H M Utidjian
Journal:  Br J Vener Dis       Date:  1972-02

8.  Chlamydia trachomatis infant pneumonitis: comparison with matched controls and other infant pneumonitis.

Authors:  H R Harrison; M G English; C K Lee; E R Alexander
Journal:  N Engl J Med       Date:  1978-03-30       Impact factor: 91.245

9.  Vaginal chemoprophylaxis in the reduction of reinfection in women with gonorrhoea. Clinical evaluation of the effectiveness of a vaginal contraceptive.

Authors:  C H Cole; T G Lacher; J C Bailey; D L Fairclough
Journal:  Br J Vener Dis       Date:  1980-10

10.  Aetiology of acute epididymitis.

Authors:  J P Harnisch; R E Berger; E R Alexander; G Monda; K K Holmes
Journal:  Lancet       Date:  1977-04-16       Impact factor: 79.321

View more
  12 in total

1.  Solubilization and in vitro spermicidal assessment of nonoxynol-9 and selected fractions using rabbit spermatozoa.

Authors:  B A Walter; A A Hawi; P M Zavos; G A Digenis
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

2.  Nonoxinol 9 and HIV infection.

Authors:  D J Jeffries
Journal:  Br Med J (Clin Res Ed)       Date:  1988-06-25

Review 3.  Barrier methods of contraception, spermicides, and sexually transmitted diseases: a review.

Authors:  L C d'Oro; F Parazzini; L Naldi; C La Vecchia
Journal:  Genitourin Med       Date:  1994-12

4.  In vitro inactivation of Chlamydia trachomatis by fatty acids and monoglycerides.

Authors:  G Bergsson; J Arnfinnsson; S M Karlsson; O Steingrímsson; H Thormar
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

5.  In vitro inhibitory effects of hinokitiol on proliferation of Chlamydia trachomatis.

Authors:  Hiroaki Yamano; Tsutomu Yamazaki; Kozue Sato; Sadashi Shiga; Toshikatsu Hagiwara; Kazunobu Ouchi; Toshio Kishimoto
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

6.  Biosynthesized tea polyphenols inactivate Chlamydia trachomatis in vitro.

Authors:  Tsutomu Yamazaki; Toshio Kishimoto; Sadashi Shiga; Kozue Sato; Toshikatsu Hagiwara; Miyuki Inoue; Nozomu Sasaki; Kazunobu Ouchi; Yukihiko Hara
Journal:  Antimicrob Agents Chemother       Date:  2005-06       Impact factor: 5.191

7.  Chlamydia trachomatis laboratory strains versus recent clinical isolates: implications for routine microbicide testing.

Authors:  M C Skinner; W E Stamm; M L Lampe
Journal:  Antimicrob Agents Chemother       Date:  2009-02-02       Impact factor: 5.191

8.  In vitro activity of nonoxynol 9 on HeLa 229 cells and primary monkey cervical epithelial cells infected with Chlamydia trachomatis.

Authors:  D L Patton; S K Wang; C C Kuo
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

9.  Susceptibility of Chlamydia trachomatis to chlorhexidine gluconate gel.

Authors:  M F Lampe; L M Ballweber; W E Stamm
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

10.  Decreased cervical epithelial sensitivity to nonoxynol-9 (N-9) after four daily applications in a murine model of topical vaginal microbicide safety.

Authors:  Karissa Lozenski; Robert Ownbey; Brian Wigdahl; Tina Kish-Catalone; Fred C Krebs
Journal:  BMC Pharmacol Toxicol       Date:  2012-10-01       Impact factor: 2.483

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.